Bortezomib-based treatment for relapsed and refractory angioimmunoblastic T-cell lymphoma: Case report and literature review

被引：4
作者：
Liu, Shuyan [1 ]
Yuan, Zhengang [1 ]
Zhang, Chunyang [1 ]
Fu, Weijun [1 ]
Hou, Jian [1 ]
机构：
[1] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Hematol, Shanghai 200003, Peoples R China
来源：
ONCOLOGY LETTERS | 2012年 / 4卷 / 02期
关键词：
bortezomib; treatment; relapsed; refractory; angioimmunoblastic T cell lymphoma; PHASE-II TRIAL; KAPPA-B; CHOP;
D O I：
10.3892/ol.2012.724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Angioimmunoblastic T-cell lymphoma (AITL) is a distinct peripheral T-cell lymphoma (PTCL) subtype, accounting for 15-20% of PTCL and 2% of all non-Hodgkin lymphoma (NHL), with a poor prognosis. In the present study, we describe a 76-year-old patient with AITL who failed to respond to conventional chemotherapy but responded to bortezomib-based treatment and demonstrated persistent clinical improvement at the 18-month follow-up. These data suggest that bortezomib-based treatment may be a reliable, safe and effective alternative for treating relapsed/refractory AITL.
引用
收藏
页码：262 / 264
页数：3
相关论文
共 16 条
[1]   Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine [J].
Advani, Ranjana ;
Horwitz, Steven ;
Zelenetz, Andrew ;
Horning, Sandra J. .
LEUKEMIA & LYMPHOMA, 2007, 48 (03) :521-525
[2]   Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience [J].
Arkenau, Hendrik-Tobias ;
Chong, Geoff ;
Cunningham, David ;
Watkins, David ;
Sirohi, Bhawna ;
Chau, Ian ;
Wotherspoon, Andrew ;
Norman, Andy ;
Horwich, Alan ;
Matutes, Estella .
HAEMATOLOGICA, 2007, 92 (02) :271-272
[3]   Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma [J].
d'Amore, Francesco ;
Radford, John ;
Relander, Thomas ;
Jerkeman, Mats ;
Tilly, Herve ;
Osterborg, Anders ;
Morschhauser, Franck ;
Gramatzki, Martin ;
Dreyling, Martin ;
Bang, Bo ;
Hagberg, Hans .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (05) :565-573
[4]   Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma [J].
Dang, Nam H. ;
Pro, Barbara ;
Hagemeister, Fredrick B. ;
Samaniego, Felipe ;
Jones, Dan ;
Samuels, Barry I. ;
Rodriguez, Maria A. ;
McLaughlin, Peter ;
Tong, Ann T. ;
Turturro, Francesco ;
Walker, Pamela L. ;
Fayad, Luis .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (03) :439-447
[5]   Advances in the understanding and management of angioimmunoblastic T-cell lymphoma [J].
de Leval, Laurence ;
Gisselbrecht, Christian ;
Gaulard, Philippe .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (05) :673-689
[6]   Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Grappo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial [J].
Gallamini, Andrea ;
Zaja, Francesco ;
Patti, Caterina ;
Billio, Atto ;
Specchia, Maria Rosaria ;
Tucci, Alessandra ;
Levis, Alessandro ;
Manna, Annunziata ;
Secondo, Vicenzo ;
Rigacci, Luigi ;
Pinto, Antonello ;
Iannitto, Emilio ;
Zoli, Valerio ;
Torchio, Pierfederico ;
Pileri, Stefano ;
Tarella, Corrado .
BLOOD, 2007, 110 (07) :2316-2323
[7]   Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation [J].
Gottardi, Michele ;
Danesin, Cristina ;
Canal, Fabio ;
Tos, Angelo Paolo Dei ;
Stefani, Piero Maria ;
Calistri, Elisabetta ;
Salvadori, Ugo ;
Gherlinzoni, Filippo .
LEUKEMIA & LYMPHOMA, 2008, 49 (09) :1836-1838
[8]   Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma [J].
Lee, J. ;
Suh, C. ;
Kang, H. J. ;
Ryoo, B. -Y. ;
Huh, J. ;
Ko, Y. H. ;
Eom, H. -S. ;
Kim, K. ;
Park, K. ;
Kim, W. S. .
ANNALS OF ONCOLOGY, 2008, 19 (12) :2079-2083
[9]   Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas [J].
Martínez-Delgado, B ;
Cuadros, M ;
Honrado, E ;
de la Parte, AR ;
Roncador, G ;
Alves, J ;
Castrillo, JM ;
Rivas, C ;
Benítez, J .
LEUKEMIA, 2005, 19 (12) :2254-2263
[10]   Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials [J].
Mourad, Nathalie ;
Mounier, Nicolas ;
Briere, Josette ;
Raffoux, Emmanuel ;
Delmer, Alain ;
Feller, Alfred ;
Meijer, Chris J. L. M. ;
Emile, Jean-Francois ;
Bouabdallah, Reda ;
Bosly, Andre ;
Diebold, Jacques ;
Haioun, Corinne ;
Coiffier, Bertrand ;
Gisselbrecht, Christian ;
Gaulard, Philippe .
BLOOD, 2008, 111 (09) :4463-4470
12